Archive · 11 Aug 2026
Lord's Mark Industries Gets India's First Gut Microbiome Analytics License
Our bodies have trillions of tiny living things in our tummies called gut microbes.
They help with digestion, immunity, metabolism and staying healthy.
A company called Lord's Mark Industries has built a special tool named Biomescan that can study these tiny microbes.
It is the first and only company in India to receive a license for this kind of tool.
The tool looks at a person's gut data and gives advice about food and lifestyle that is just right for them.
This can help people stay healthy before they get sick, like an early warning check.
The company plans to open 3,000 health and wellness centers across India in the next three years.
It will also launch an app-based service soon.
The gut health market in India is growing quickly and is expected to get much bigger.
The tool is meant for wellness and health information, and it does not diagnose diseases by itself.
Lord's Mark Industries Limited has become India's first and only company to receive a manufacturing licence for an In Vitro Diagnostic Software (Software as a Medical Device - SaMD) for its Biomescan Analytics Platform.
Biomescan uses whole metagenome sequencing data and a validated bioinformatics pipeline to generate gut microbiome profiles, diversity scores, enterotype classification and personalized dietary recommendations.
India's gut health market was valued at USD 565.51 million in 2025 and is projected to reach USD 1,619.56 million by 2034, growing at a CAGR of 11.07%.
The company plans to establish 3,000 Health & Wellness Centres across India within the next three years and launch app-based services soon.
The platform is licensed as a wellness and health-information tool and is not intended for standalone clinical diagnosis or therapeutic decision-making.
- Who
- Lord's Mark Industries Limited, an Indian company led by Managing Director Sachidanand Upadhyay.
- What
- Received India's first manufacturing licence for its Biomescan gut microbiome analytics platform, an In Vitro Diagnostic Software (Software as a Medical Device).
- When
- Exact date not stated in the article.
- Where
- India
- Why
- To promote preventive healthcare by enabling early intervention and personalized nutrition based on gut microbiome insights, before disease develops.
- Company
- Lord's Mark Industries Limited
- Platform
- Biomescan Analytics Platform
- License
- Manufacturing licence for In Vitro Diagnostic Software (Software as a Medical Device - SaMD)
- Market Position
- India's first and only company to receive the licence
- India Gut Health Market Value (2025)
- USD 565.51 million
- Projected Market Value (2034)
- USD 1,619.56 million
- Expected CAGR
- 11.07%
- Planned Wellness Centres
- 3,000 centres across India within 3 years